Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells

被引:101
作者
Sen, CK
Khanna, S
Reznick, AZ
Roy, S
Packer, L
机构
[1] UNIV KUOPIO,DEPT PHYSIOL,FAC MED,FIN-70211 KUOPIO,FINLAND
[2] TECHNION ISRAEL INST TECHNOL,FAC MED,MUSCULO SKELETAL LAB,HAIFA,ISRAEL
关键词
D O I
10.1006/bbrc.1997.7206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TNF alpha is implicated in several skeletal muscle pathologies including muscle wasting of cachexia. Muscle wasting and other conditions such as physical exercise and immobilization are also associated with disturbances in muscle glutathione status. Hence, it was of interest to investigate the role of endogenous glutathione status in TNF alpha induced NF-kappa B activation in skeletal muscle-derived cells. TNF alpha proved to be a potent inducer of transient NF-kappa B activation in L6 myoblasts. In buthioninesulfoximine (BSO) treated cells, TNF alpha induced NF-kappa B activation was markedly potentiated suggesting that such activation is sensitive to cellular GSH, but may have been independent of high levels of intracellular GSSG. Because this activation was inhibited by the antioxidant pyrrolidinedithiocarbamate (PDTC) the involvement of reactive oxygen species in this activation system seems likely. NF-kappa B activation in L6 cells was also observed in response to direct H2O2 treatment. Results from GSSG reductase inhibited cells suggest that GSSG may participate in, but is not required for, TNF alpha induced NF-kappa B activation. The inhibitory effect of PDTC on NF-kappa B activation correlated with its effect on ICAM-1 expression suggesting that this GSH status modifying agent not only influenced nuclear translocation of NF-kappa B proteins but also regulated kappa B dependent transcription. (C) 1997 Academic Press.
引用
收藏
页码:645 / 649
页数:5
相关论文
共 31 条
[1]   BIOLOGY OF MULTIFUNCTIONAL CYTOKINES - IL-6 AND RELATED MOLECULES (IL-1 AND TNF) [J].
AKIRA, S ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
FASEB JOURNAL, 1990, 4 (11) :2860-2867
[2]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[3]   TUMOR NECROSIS FACTOR-ALPHA INHIBITS ALBUMIN GENE-EXPRESSION IN A MURINE MODEL OF CACHEXIA [J].
BRENNER, DA ;
BUCK, M ;
FEITELBERG, SP ;
CHOJKIER, M .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :248-255
[4]   Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants [J].
Buck, M ;
Chojkier, M .
EMBO JOURNAL, 1996, 15 (08) :1753-1765
[5]   CACHEXIA AND GRAFT-VS-HOST-DISEASE-TYPE SKIN CHANGES IN KERATIN PROMOTER-DRIVEN TNF-ALPHA TRANSGENIC MICE [J].
CHENG, J ;
TURKSEN, K ;
YU, QC ;
SCHREIBER, H ;
TENG, M ;
FUCHS, E .
GENES & DEVELOPMENT, 1992, 6 (08) :1444-1456
[6]   TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS [J].
COLLINS, T ;
READ, MA ;
NEISH, AS ;
WHITLEY, MZ ;
THANOS, D ;
MANIATIS, T .
FASEB JOURNAL, 1995, 9 (10) :899-909
[7]   TUMOR-NECROSIS-FACTOR-ALPHA MEDIATES CHANGES IN TISSUE PROTEIN-TURNOVER IN A RAT CANCER CACHEXIA MODEL [J].
COSTELLI, P ;
CARBO, N ;
TESSITORE, L ;
BAGBY, GJ ;
LOPEZSORIANO, FJ ;
ARGILES, JM ;
BACCINO, FM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2783-2789
[8]  
Droge W, 1997, Adv Pharmacol, V38, P581
[9]  
DROGE W, 1994, FASEB J, V8, P1131
[10]   INVOLVEMENT OF REACTIVE OXYGEN INTERMEDIATES IN CYCLOOXYGENASE-2 EXPRESSION INDUCED BY INTERLEUKIN-1, TUMOR-NECROSIS-FACTOR-ALPHA, AND LIPOPOLYSACCHARIDE [J].
FENG, L ;
XIA, YY ;
GARCIA, GE ;
HWANG, D ;
WILSON, CB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1669-1675